Stock Performance of Abbott Laboratories and CrowdStrike

Welcome back to another exciting clip of Market Mondays! In today's session, Ian Dunlap, Rashad Bilal, and Troy Millings dive deep into the latest stock updates to help you make informed investment decisions. Whether you’re a seasoned investor or just starting, this episode is packed with valuable insights.

In This Episode

*Adobe's AI Advancements:*

We start the episode by discussing Adobe and their recent earnings call, which saw the stock price soar by 15%. Adobe unveiled some major advancements in the world of artificial intelligence, but is it too little too late? Ian shares his candid thoughts on Adobe’s position in the AI landscape and whether it’s worth adding to your portfolio.

*Automatic Data Processing (ADP):*

Next, Troy brings up ADP, a global technology company specializing in HR, payroll, talent, time, and tax services. While the company has performed well traditionally, is it the best option in its category? Ian provides a nuanced take, putting ADP into the "maybe one day" folder and discussing its pros and cons.

*Abbott Laboratories:*

We then shift our focus to Abbott Laboratories, a global healthcare company that's down 6% year-to-date. Should you consider dating or dumping this stock? Ian talks about the competition in the healthcare space and under what conditions Abbott Laboratories could be a good pick for long-term investors.

*CrowdStrike:*

One of the highlights of this episode is the discussion around CrowdStrike, a leader in endpoint security. Up 55% year-to-date, CrowdStrike has managed to establish itself as a front-runner in the cybersecurity field. Ian enthusiastically endorses CrowdStrike, even coining a new phrase – "love bombing" – to describe his investment strategy for this stock.

*Newmont Corporation:*

On a different note, we explore Newmont Corporation, a major player in the gold, copper, zinc, and lead production sectors. Unfortunately, the outlook isn’t too rosy, with Ian giving it a definitive "hell no" due to its high volatility and poor past performance.

*Capital One:*

Finally, we evaluate Capital One. Despite having a decent run post-pandemic, Ian advises against investing in this financial services company, favoring other options in the banking sector like Chase or BlackRock.

Key Takeaways

- *Stock Picks:* Understand which stocks are worth dating and which ones you should dump.

- *AI & Cybersecurity:* Learn about the leading companies in these rapidly evolving sectors.

- *Sector Analysis:* Get insights into healthcare, financial services, and technology stocks.

- *Investment Strategies:* Practical tips to help you make better investment choices.

If you’re enjoying this series, don’t forget to like, comment, and subscribe for more episodes!

*Timestamps:*

- 00:00 - Introduction

- 00:04 - Adobe’s AI Advancements

- 02:01 - Automatic Data Processing (ADP)

- 03:35 - Abbott Laboratories

- 05:07 - CrowdStrike

- 06:26 - Newmont Corporation

- 07:21 - Capital One

*Join the Conversation:*

Have any questions or comments about today's episode? Drop them below, and let's discuss!

*Credits:*

Hosted by Ian Dunlap, Rashad Bilal, and Troy Millings.

*Disclaimer:*

The information provided in this episode is for educational and informational purposes only and should not be construed as financial advice. Always consult with a professional before making any investment decisions.

#MarketMondays #StocksToWatch #Investing #Adobe #ADP #AbbottLaboratories #CrowdStrike #Newmont #CapitalOne #FinancialFreedom #InvestmentTips

Tune in next week for more insights and stock breakdowns from the Market Mondays team!

---

Don't miss out on our future episodes; hit that notification bell and stay savvy with your investments!